Hubei Hongyuan Pharmaceutical Technology Co., Ltd. Stock: price and insider trades · China
宏源药业
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.: what insiders have been doing
Hubei Hongyuan Pharmaceutical Technology Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). Nothing new has been filed by managers of Hubei Hongyuan Pharmaceutical Technology Co., Ltd. in twelve months, the latest record being from 8 August 2024.
The full history, which starts in 2024, counts no purchases against 7 sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 100,000 shares20.1% of flowA股XSHESZSE:173000007935444930
- 100,000 shares20.0% of flowA股XSHESZSE:173000007925804130
- 174,000 shares35.0% of flowA股XSHESZSE:173000007917512350
- 126,000 shares24.9% of flowA股XSHESZSE:173000007910362850
- 20,000 shares49.2% of flowA股XSHESZSE:173000007870985300
- 20,000 shares50.8% of flowA股XSHESZSE:173000007844097060
- 500 shares100.0% of flowA股XSHESZSE:173000007455222850
7 of 7 declarations
About Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
宏源药业 is a company specializing in the health and pharmaceutical sector. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
